-+ 0.00%
-+ 0.00%
-+ 0.00%

BOLT BIOTHERAPEUTICS ANNOUNCES ACQUISITION OF PRANA THERAPIES AND $120 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE PRA-216 IN MULTIPLE HIGH-VALUE INFLAMMATORY INDICATIONS

Reuters·10/23/2026 13:10:06